Global HIV Programme
The WHO Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of HIV as a public health threat.

Strategic Information

Data helps to focus and guide public health interventions, both globally and in countries, to improve the delivery of health services to all people. The WHO Department of Global HIV, Hepatitis and Sexually Transmitted Infections (HHS) programme focuses on people-centred data to improve prevention, testing and treatment services.

WHO provides global reports; collects and validates data with partners through the Global AIDS Monitoring mechanism; and develops guidelines for strategic information, case surveillance, patient monitoring, digital health and data use. The strategic information team works with regions and countries to strengthen monitoring and evaluation systems, which are a key building block in country health systems.

Latest policy guidance

Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact
These consolidated guidelines are aimed at supporting the generation of responsive person-centred data from routine national health management information...

Policy briefs

Policy brief on person-centred monitoring to focus prevention and guide programmes

Measuring HIV prevention programmes against health outcomes (such as individuals remaining HIV-negative or new HIV infections) can be challenging. This...

Policy brief on integrating and strengthening monitoring of differentiated ART service delivery

These recommendations include approaches for differentiated service delivery (DSD) of antiretroviral therapy (ART) that are less intensive and provide...

Policy brief on digital health data

The new Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact 1 aim to help countries improve how...

Policy brief on integrating related infections into HIV surveillance systems

Sexually transmitted infections (STIs), viral hepatitis and cervical cancer are important concerns for any country implementing HIV programmes because...

Policy brief on harnessing the strength of routine data for HIV surveillance

Programmatic data routinely collected at service delivery sites can play an important role in the measuring and monitoring of HIV incidence and prevalence,...

Enhancing the monitoring of HIV testing and treatment

Person-centred monitoring generates individual level data to monitor the health status of people living with HIV over time and ensure the quality and continuity...

Technical documents

WHO Data quality assessment of national and partner monitoring data and system implementation tool – Second edition

This technical brief summarizes key updates to the 2018 Data quality assessment of national and partner HIV treatment and patient monitoring data and systems...

Module for assessing and strengthening the quality of viral load testing data within HIV programmes andpatient monitoring systems: second edition

This technical update of the 2020 viral load data quality module provides further guidance on the recommended data quality assurance activities, updated...

Using recency assays for HIV surveillance: 2022 technical guidance

Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency...

Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021

This report provides accountability for the 3 Global Health Sector Strategies (2016-2021) on HIV, Viral Hepatitis and the STIs. The report assesses the...

Module for assessing and strengthening the quality of viral load testing data within HIV programmes and  patient monitoring systems

The overarching goal of this module is to support the assessment of data quality (DQ), strengthen data and patient monitoring systems and support data...

HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis

WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV...

Surveillance of antiretroviral toxicity: global HIV, hepatitis and STIs programme: what's new in person-centred HIV patient and antiretroviral drug toxicity monitoring

In April 2020, new directions in global guidance for HIV strategic information and treatment monitoring were updated. This technical update outlines the...

Considerations for developing a monitoring and evaluation framework for viral load testing

The WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommend viral load as the preferred monitoring...

Data quality assessment of national and partner HIV treatment and patient monitoring data and systems implementation tool

In the past decade, national programmes and donor-funded projects have made great progress in reaching people living with HIV with life-saving treatment...

HIV strategic information for impact: cascade data use manual: to identify gaps in HIV and health services for programme improvement: user manual

This guide supports the use of data to identify and fill gaps in services in order to improve HIV and health programmes. Following from the Consolidated...

Surveillance of HIV drug resistance in children newly diagnosed with HIV by early infant diagnosis

 This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months...

Biobehavioural survey guidelines for populations at risk for HIV

The guidelines fill a gap in providing tools for surveying HIV prevalence in key populations, and the included questionnaires may also inform general population...